MYL

Recent Articles

16 Pharmaceuticals Stocks to Sell Now

The overall ratings of 16 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

13 Pharmaceuticals Stocks to Sell Now

The ratings of 13 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

26 Pharmaceuticals Stocks to Sell Now

The ratings of 26 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

Buy the SPDR S&P Biotech (ETF) (XBI) TODAY – Here’s Why

Biotech stocks and the SPDR S&P Biotech ETF (XBI) just shook off a major bugaboo in Hillary Clinton. The XBI ETF will soar as a result. More 

Valeant Pharmaceuticals Intl Inc (VRX) Stock Enters ‘Survivor Mode’

Valeant Pharmaceuticals (VRX) has to sell the family silver to pay debts, and its business model is under attack. VRX stock might not make it. More 

3 Stocks to Watch on Tuesday: Hertz Global Holdings, Inc (HTZ), Priceline Group Inc (PCLN) and Mylan NV (MYL)

Hertz (HTZ) is cratering on earnings, Priceline (PCLN) earned a boost off its report and Mylan (MYL) is back in headlines over EpiPen issues. More 

3 Pharma Stocks That Could Be Gutted If Marijuana Wins

If marijuana initiatives perform well on Election Day, opioid pharma stocks such as MYL, DEPO and INSY could be the big losers. More